Skip to main content

Main menu

  • Home
  • Current issue
  • Early View
  • Archive
  • Authors/reviewers
    • Instructions for authors
    • Submit a manuscript
    • COVID-19 submission information
    • Institutional open access agreements
    • Peer reviewer login
  • Alerts
  • Subscriptions
  • ERS Publications
    • European Respiratory Journal
    • ERJ Open Research
    • European Respiratory Review
    • Breathe
    • ERS Books
    • ERS publications home

User menu

  • Log in
  • Subscribe
  • Contact Us
  • My Cart

Search

  • Advanced search
  • ERS Publications
    • European Respiratory Journal
    • ERJ Open Research
    • European Respiratory Review
    • Breathe
    • ERS Books
    • ERS publications home

Login

European Respiratory Society

Advanced Search

  • Home
  • Current issue
  • Early View
  • Archive
  • Authors/reviewers
    • Instructions for authors
    • Submit a manuscript
    • COVID-19 submission information
    • Institutional open access agreements
    • Peer reviewer login
  • Alerts
  • Subscriptions

Single-inhaler triple therapy in symptomatic COPD patients: FULFIL subgroup analyses

David M.G. Halpin, Ruby Birk, Noushin Brealey, Gerard J. Criner, Mark T. Dransfield, Emma Hilton, David A. Lomas, Chang-Qing Zhu, David A. Lipson
ERJ Open Research 2018 4: 00119-2017; DOI: 10.1183/23120541.00119-2017
David M.G. Halpin
1Dept of Respiratory Medicine, Royal Devon and Exeter Hospital, Exeter, UK
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Ruby Birk
2GSK, Uxbridge, UK
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Noushin Brealey
2GSK, Uxbridge, UK
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Gerard J. Criner
3Lewis Katz School of Medicine at Temple University, Philadelphia, PA, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Mark T. Dransfield
4Division of Pulmonary, Allergy and Critical Care Medicine, Lung Health Center, University of Alabama at Birmingham, Birmingham, AL, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Emma Hilton
2GSK, Uxbridge, UK
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
David A. Lomas
5UCL Respiratory, University College London, London, UK
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Chang-Qing Zhu
2GSK, Uxbridge, UK
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
David A. Lipson
6GSK, King of Prussia, PA, USA
7Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
  • PDF
Loading

Article Information

vol. 4 no. 2
DOI 
https://doi.org/10.1183/23120541.00119-2017

Published By 
European Respiratory Society
Online ISSN 
2312-0541
History 
  • Received September 26, 2017
  • Accepted March 9, 2018
  • Published online May 4, 2018.

Copyright & Usage 
The content of this work is copyright of the authors or their employers. Design and branding are copyright ©ERS 2018 This article is open access and distributed under the terms of the Creative Commons Attribution Non-Commercial Licence 4.0.

Author Information

  1. David M.G. Halpin1,
  2. Ruby Birk2,
  3. Noushin Brealey2,
  4. Gerard J. Criner3,
  5. Mark T. Dransfield4,
  6. Emma Hilton2,
  7. David A. Lomas5,
  8. Chang-Qing Zhu2 and
  9. David A. Lipson6,7
  1. 1Dept of Respiratory Medicine, Royal Devon and Exeter Hospital, Exeter, UK
  2. 2GSK, Uxbridge, UK
  3. 3Lewis Katz School of Medicine at Temple University, Philadelphia, PA, USA
  4. 4Division of Pulmonary, Allergy and Critical Care Medicine, Lung Health Center, University of Alabama at Birmingham, Birmingham, AL, USA
  5. 5UCL Respiratory, University College London, London, UK
  6. 6GSK, King of Prussia, PA, USA
  7. 7Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA
  1. David M.G. Halpin, Dept of Respiratory Medicine, Royal Devon and Exeter Hospital, Barrack Road, Exeter, EX2 5DW, UK. E-mail: d.halpin{at}nhs.net
View Full Text

Funding

  • GlaxoSmithKline

    CTT116853

Article usage

Article usage: May 2018 to December 2022

AbstractFullPdf
May 20181534164
Jun 20180211145
Jul 2018112843
Aug 2018012344
Sep 2018218551
Oct 2018333459
Nov 2018230546
Dec 2018225628
Jan 2019619727
Feb 2019523231
Mar 2019312830
Apr 201918259
May 201966434
Jun 201959934
Jul 201919727
Aug 201929528
Sep 201959832
Oct 2019413145
Nov 201966226
Dec 201927430
Jan 2020812880
Feb 202076024
Mar 202019316
Apr 2020610031
May 202056053
Jun 202037229
Jul 202037124
Aug 2020113022
Sep 202026044
Oct 202055339
Nov 202063820
Dec 202032418
Jan 202123315
Feb 20212508
Mar 202185530
Apr 202195522
May 202124518
Jun 202134319
Jul 202162325
Aug 20212297
Sep 202144115
Oct 202172130
Nov 2021113121
Dec 202114216
Jan 20226257
Feb 202223610
Mar 202222617
Apr 20222910
May 202213924
Jun 20223177
Jul 202222920
Aug 202263420
Sep 202252223
Oct 202232832
Nov 202213529
Dec 202211511

Altmetrics

PreviousNext
Back to top
Vol 4 Issue 2 Table of Contents
ERJ Open Research: 4 (2)
  • Table of Contents
  • Index by author
Email

Thank you for your interest in spreading the word on European Respiratory Society .

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Single-inhaler triple therapy in symptomatic COPD patients: FULFIL subgroup analyses
(Your Name) has sent you a message from European Respiratory Society
(Your Name) thought you would like to see the European Respiratory Society web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Print
Citation Tools
Single-inhaler triple therapy in symptomatic COPD patients: FULFIL subgroup analyses
David M.G. Halpin, Ruby Birk, Noushin Brealey, Gerard J. Criner, Mark T. Dransfield, Emma Hilton, David A. Lomas, Chang-Qing Zhu, David A. Lipson
ERJ Open Research Apr 2018, 4 (2) 00119-2017; DOI: 10.1183/23120541.00119-2017

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Single-inhaler triple therapy in symptomatic COPD patients: FULFIL subgroup analyses
David M.G. Halpin, Ruby Birk, Noushin Brealey, Gerard J. Criner, Mark T. Dransfield, Emma Hilton, David A. Lomas, Chang-Qing Zhu, David A. Lipson
ERJ Open Research Apr 2018, 4 (2) 00119-2017; DOI: 10.1183/23120541.00119-2017
del.icio.us logo Digg logo Reddit logo Technorati logo Twitter logo CiteULike logo Connotea logo Facebook logo Google logo Mendeley logo
Full Text (PDF)

Jump To

  • Article
    • Abstract
    • Abstract
    • Introduction
    • Methods
    • Results
    • Discussion
    • Supplementary material
    • Acknowledgements
    • Footnotes
    • References
  • Figures & Data
  • Info & Metrics
  • PDF

Subjects

  • COPD and smoking
  • Tweet Widget
  • Facebook Like
  • Google Plus One

More in this TOC Section

Original articles

  • Endobronchial autologous BM-MSCs in IPF patients
  • Effect of β-blockers on the risk of COPD exacerbations
  • Recurrence of symptoms after childhood LRTI
Show more Original articles

COPD

  • Admissions following first exacerbation-related hospitalisation
  • Improving the wellbeing of caregivers of patients with COPD
  • Arterial remodelling in smokers, and patients with small airway disease and COPD
Show more COPD

Related Articles

Navigate

  • Home
  • Current issue
  • Archive

About ERJ Open Research

  • Editorial board
  • Journal information
  • Press
  • Permissions and reprints
  • Advertising

The European Respiratory Society

  • Society home
  • myERS
  • Privacy policy
  • Accessibility

ERS publications

  • European Respiratory Journal
  • ERJ Open Research
  • European Respiratory Review
  • Breathe
  • ERS books online
  • ERS Bookshop

Help

  • Feedback

For authors

  • Instructions for authors
  • Publication ethics and malpractice
  • Submit a manuscript

For readers

  • Alerts
  • Subjects
  • RSS

Subscriptions

  • Accessing the ERS publications

Contact us

European Respiratory Society
442 Glossop Road
Sheffield S10 2PX
United Kingdom
Tel: +44 114 2672860
Email: journals@ersnet.org

ISSN

Online ISSN: 2312-0541

Copyright © 2023 by the European Respiratory Society